BILL ELLIOT;CHASE, TANIA ROBYN;CHAM, KAI ELLIOT;CHAM;CHAM, BILL ELLIOT
发明人:
CHAM, BILL ELLIOT,CHASE, TANIA ROBYN,CHAM, KAI ELLIOT
申请号：
CA3016729
公开号：
CA3016729A1
申请日:
2017.03.03
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to the use of glycoalkaloids, such as solasonine and solamargine, in treatment of cancer such as skin cancer, and to compositions for use in such treatment. More particularly the present invention relates to providing an improved, substantially stable formulation for the glycoalkaloids which minimises or reduces degradation of these active molecules.
